Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 179 active Chronic Lymphocytic Leukemia trials
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Study Type: Interventional Phase 1
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
Study Type: Observational
Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Study Type: Interventional Phase 2
Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
Study Type: Interventional Phase 1
Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.
Study Type: Interventional Phase 1
Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies
Study Type: Interventional Phase 1
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
Study Type: Interventional Phase 2
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Study Type: Interventional Phase 2
There are 179 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now